MONTREAL, CANADA--(Marketwire - October 03, 2007) - ART Advanced Research Technologies Inc. (“ART”) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that Mr. Sebastien Gignac, the Company’s President & CEO, will present ART’s recent developments in achieving key milestones at the BioContact Quebec 2007 investor conference, to be held at the Fairmount Chateau Frontenac in Quebec City (Canada) from October 3 to 5. Mr. Gignac is scheduled to present on Thursday, October 4, 2007, at 2:00 p.m. (EST) in the Laval Room.
